GE HealthCare Technologies (NASDAQ:GEHC) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen lowered shares of GE HealthCare Technologies (NASDAQ:GEHC) from a buy rating to a hold rating in a research report sent to investors on Saturday morning.

GEHC has been the subject of a number of other reports. Stifel Nicolaus boosted their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research note on Wednesday, February 4th. Bank of America lifted their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a report on Monday, January 5th. Morgan Stanley upped their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 4th. The Goldman Sachs Group reissued a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a report on Friday, January 9th. Finally, UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their target price for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $92.17.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $69.61 on Friday. The firm’s 50-day moving average price is $79.22 and its 200-day moving average price is $78.43. GE HealthCare Technologies has a 52-week low of $57.65 and a 52-week high of $89.77. The company has a market cap of $31.72 billion, a PE ratio of 15.26, a PEG ratio of 1.53 and a beta of 1.03. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. During the same period in the previous year, the company earned $1.45 earnings per share. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is 3.07%.

Hedge Funds Weigh In On GE HealthCare Technologies

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. increased its position in GE HealthCare Technologies by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after buying an additional 267,058 shares in the last quarter. Auto Owners Insurance Co lifted its position in shares of GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after buying an additional 33,629,559 shares in the last quarter. Dodge & Cox grew its stake in shares of GE HealthCare Technologies by 13.4% during the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after acquiring an additional 3,693,918 shares during the period. Capital Research Global Investors grew its stake in shares of GE HealthCare Technologies by 1.6% during the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after acquiring an additional 389,796 shares during the period. Finally, State Street Corp increased its holdings in GE HealthCare Technologies by 2.0% in the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock worth $1,644,475,000 after acquiring an additional 401,932 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.